CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment

J Wen, S Wang, R Guo, D Liu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Abstract ABSTRACT: Colony-Stimulating Factor-1 Receptor (CSF1R) is a receptor tyrosine
kinase that controls the differentiation and maintenance of most tissue-resident …
被引用次数：37 相关文章

CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment

J Wen, S Wang, R Guo, D Liu - European journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Colony-Stimulating Factor-1 Receptor (CSF1R) is a receptor tyrosine kinase that controls the
differentiation and maintenance of most tissue-resident macrophages and bone-resorbing …

[引用][C] CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment

J Wen, S Wang, R Guo, D Liu - European Journal of Medicinal Chemistry, 2023 - cir.nii.ac.jp
CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文 …

CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment.

J Wen, S Wang, R Guo, D Liu - European Journal of Medicinal …, 2022 - europepmc.org
Colony-Stimulating Factor-1 Receptor (CSF1R) is a receptor tyrosine kinase that controls the
differentiation and maintenance of most tissue-resident macrophages and bone-resorbing …